U.S. HHS Awards $226M To Sanofi Pasteur To Enhance Influenza Vaccine Production Capabilities

Homeland Preparedness News: DHHS awards Sanofi Pasteur $226M for expansion of influenza pandemic preparedness efforts
“Per an agreement with the U.S. Department of Health and Human Services (DHHS), Sanofi Pasteur will gain $226 million to increase its domestic pandemic influenza vaccine production capabilities. … This, Sanofi says, will bolster U.S. and global pandemic preparedness…” (Galford, 12/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.